Baudax Bio, Inc.
BXRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 310.00K | 548.00K | 848.00K | 1.27M | 1.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 310.00K | 548.00K | 848.00K | 1.27M | 1.36M |
| Cost of Revenue | 4.79M | 4.79M | 4.79M | 4.79M | 576.00K |
| Gross Profit | -4.48M | -4.48M | -4.48M | -4.48M | -176.00K |
| SG&A Expenses | 9.76M | 9.07M | 9.71M | 14.88M | 24.33M |
| Depreciation & Amortization | 65.00K | 65.00K | 65.00K | 65.00K | 644.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.25M | 20.28M | 20.03M | 22.97M | 28.24M |
| Operating Income | -21.94M | -19.97M | -19.72M | -22.66M | -27.84M |
| Income Before Tax | -25.83M | -28.02M | -25.07M | -25.88M | 12.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.83 | -28.02 | -25.07 | -25.88 | 12.81 |
| Earnings from Discontinued Operations | 18.67M | -6.40M | -9.52M | -32.92M | -32.92M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.16M | -34.43M | -34.58M | -58.80M | -20.11M |
| EBIT | -21.94M | -19.97M | -19.72M | -22.66M | -27.84M |
| EBITDA | -21.76M | -19.92M | -19.65M | -22.58M | -27.76M |
| EPS Basic | -9.22 | -107.63 | -148.06 | -279.85 | 218.73 |
| Normalized Basic EPS | -10.26 | -18.73 | -32.94 | -81.67 | -213.14 |
| EPS Diluted | -9.22 | -107.63 | -148.06 | -279.85 | 169.53 |
| Normalized Diluted EPS | -10.26 | -18.73 | -32.94 | -81.67 | -199.11 |
| Average Basic Shares Outstanding | 15.95M | 8.25M | 3.54M | 1.33M | 636.90K |
| Average Diluted Shares Outstanding | 15.95M | 8.25M | 3.54M | 1.33M | 643.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |